Tsumura & Co.

Tokyo Stock Exchange:4540.T

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Chemicals & Advanced Materials

💊 Drugstores & Retail Pharmacies

🌿 Fertilizers

🛍 Specialty Retail

Location

Japan

Market Cap

USD 1.79 B

Share Price

USD 24.03

Avg Daily Volume

558,009

Change (1 day)

-0.13%

Change (1 year)

-6.98%

Change (YTD)

-19.90%

Tsumura & Co. Revenue Per Share for the year ending March 31, 2025: USD 15.90

Tsumura & Co. Revenue Per Share is USD 15.90 for the year ending March 31, 2025, a 21.26% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Tsumura & Co. Revenue Per Share for the year ending March 31, 2024 was USD 13.11, a -4.91% change year over year.
Tsumura & Co. Revenue Per Share for the year ending March 31, 2023 was USD 13.79, a -0.86% change year over year.
Tsumura & Co. Revenue Per Share for the year ending March 31, 2022 was USD 13.91, a -9.95% change year over year.
Tsumura & Co. Revenue Per Share for the year ending March 31, 2021 was USD 15.45, a 3.09% change year over year.

Competitors

Divi's Laboratories Limited

USD 81.61

DIVISLAB.NS

+1.44 1.79%

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.64

600436.SS

+0.16 0.57%

BioMarin Pharmaceutical Inc.

USD 57.41

BMRN

-0.09 -0.16%

Kyowa Kirin Co., Ltd.

USD 17.13

4151.T

-0.01 -0.08%

Abbott India Limited

USD 405.35

ABBOTINDIA.NS

+4.01 1.00%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.65

002422.SZ

-0.16 -3.24%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.30

688336.SS

-0.02 -0.26%

SCHOTT Pharma AG & Co. KGaA

USD 30.79

1SXP.F

-0.81 -2.57%

Dong-E-E-Jiao Co.,Ltd.

USD 7.13

000423.SZ

-0.01 -0.19%

Livzon Pharmaceutical Group Inc.

USD 3.79

1513.HK

-0.03 -0.66%

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 4.06

002773.SZ

-0.06 -1.45%

China Medical System Holdings Limited

USD 1.56

0867.HK

-0.00 -0.15%

Kangmei Pharmaceutical Co., Ltd.

USD 0.27

600518.SS

+0.00 0.04%

Gland Pharma Limited

USD 21.89

GLAND.NS

+0.07 0.34%

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.40

000623.SZ

+0.01 0.51%

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.62

600062.SS

+0.00 0.15%

Yifan Pharmaceutical Co., Ltd.

USD 2.02

002019.SZ

+0.11 5.58%

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.54

002755.SZ

+0.03 1.15%

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.70

9989.HK

+0.00 0.01%

Concord Biotech Limited

USD 20.28

CONCORDBIO.NS

-0.22 -1.05%

Key Data

Date	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share	Debt to Equity Ratio